{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:31:43Z","timestamp":1791264703475,"version":"4.1.0"},"reference-count":68,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2020-NR049589"],"award-info":[{"award-number":["RS-2020-NR049589"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-00555975"],"award-info":[{"award-number":["RS-2025-00555975"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gachon University research fund of 2020","award":["GCU-202008420008"],"award-info":[{"award-number":["GCU-202008420008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hydantoins, exemplified by the imidazolidine-2,4-dione core, are privileged scaffolds in medicinal chemistry due to their compact structure, versatile hydrogen-bonding capacity, ability to fine-tune physicochemical properties for drug-like molecules, and potential to engage a diverse array of biological targets. This review highlights major advances in hydantoin-based drug discovery since 2019, emphasizing their evolving applications in oncology; neurology; infectious diseases; and cardiovascular, metabolic, and immune disorders. Recent studies demonstrate their success as kinase inhibitors, androgen receptor antagonists, and metalloprotease inhibitors, and emerging roles in modulating sterol isomerase, glycogen synthase kinase-3\u03b2, and ADAMTS family enzymes. Novel hybrid scaffolds\u2014such as catechol\u2013hydantoins, \u03b2-carboline\u2013hydantoins, and spirocyclic thiohydantoins\u2014have yielded potent and selective anticancer and antiviral leads. The discovery of BAY-9835 and GLPG1972 underscores the clinical potential of hydantoin-based metalloproteinase inhibitors in cardiovascular and osteoarthritic conditions. Furthermore, new antimicrobial, antimalarial, and antileishmanial derivatives illustrate the scaffold\u2019s capacity to address multidrug resistance and neglected tropical diseases. Advances in computational design, stereochemical optimization, and hybridization strategies have expanded the structural and functional diversity of hydantoins, enhancing their target selectivity and pharmacokinetic profiles. Overall, hydantoins and their analogs remain at the forefront of small-molecule drug discovery, offering rich prospects for therapeutic innovation in diverse disease areas.<\/jats:p>","DOI":"10.3390\/molecules31050779","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:51:29Z","timestamp":1772117489000},"page":"779","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent Applications of Hydantoins in Drug Discovery: Updates (2019~Present)"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9685-1945","authenticated-orcid":false,"given":"Jyoti Dnyaneshwar","family":"Palkhede","sequence":"first","affiliation":[{"name":"Gachon Institute of Pharmaceutical Sciences and College of Pharmacy, Gachon University, Hambakmoe-ro 191, Yeonsu-gu, Incheon 21936, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eo-Jin","family":"Park","sequence":"additional","affiliation":[{"name":"Gachon Institute of Pharmaceutical Sciences and College of Pharmacy, Gachon University, Hambakmoe-ro 191, Yeonsu-gu, Incheon 21936, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Darlami","sequence":"additional","affiliation":[{"name":"Gachon Institute of Pharmaceutical Sciences and College of Pharmacy, Gachon University, Hambakmoe-ro 191, Yeonsu-gu, Incheon 21936, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Shin","sequence":"additional","affiliation":[{"name":"Gachon Institute of Pharmaceutical Sciences and College of Pharmacy, Gachon University, Hambakmoe-ro 191, Yeonsu-gu, Incheon 21936, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.12.066","article-title":"Recent applications of hydantoin and thiohydantoin in medicinal chemistry","volume":"164","author":"Cho","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.63001\/tbs.2024.v19.i02.S2.pp88-92","article-title":"The Multifaceted Biological Activities of Hydantoin Derivatives: From Antimicrobial to Anticancer Agents","volume":"19","author":"Sudani","year":"2024","journal-title":"Bioscan"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1021\/acs.chemrev.7b00067","article-title":"Colacino, Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold","volume":"117","author":"Konnert","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/epi4.12268","article-title":"Brief history of anti-seizure drug development","volume":"3","author":"Rho","year":"2018","journal-title":"Epilepsia Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2008.02.024","article-title":"Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins","volume":"44","author":"Zhu","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1016\/j.bmc.2011.08.017","article-title":"Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4-diones","volume":"19","author":"Byrtus","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ejmech.2008.06.029","article-title":"Synthesis of amidine and amide derivatives and their evaluation for anti-inflammatory and analgesic activities","volume":"44","author":"Sondhi","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.intimp.2011.07.010","article-title":"Anti-inflammatory and antinociceptive activities of indole-imidazolidine derivatives","volume":"11","author":"Malta","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/j.ejmech.2011.09.032","article-title":"Amine\u2013alkyl derivatives of hydantoin: New tool to combat resistant bacteria","volume":"46","author":"Handzlik","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1248\/cpb.58.1123","article-title":"Antibacterial activity of 5-dialkylaminomethylhydantoins and related compounds","volume":"58","author":"Fujisaki","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bcp.2008.10.018","article-title":"Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells","volume":"77","author":"Kavitha","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.bmcl.2006.05.010","article-title":"5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity","volume":"16","author":"Carmi","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1016\/j.bmc.2009.06.004","article-title":"Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells","volume":"17","author":"Basappa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/jm901488g","article-title":"Structure\u2212Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)","volume":"53","author":"Jung","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00396a037","article-title":"Spiro Hydantoin Aldose Reductase Inhibitors","volume":"31","author":"Sarges","year":"1988","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1016\/j.bmcl.2008.06.081","article-title":"Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties","volume":"18","author":"Sergent","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/S0960-894X(01)00654-0","article-title":"Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection","volume":"11","author":"Kim","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/S0960-894X(01)00655-2","article-title":"Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection","volume":"11","author":"Kim","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/ml1002647","article-title":"Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes","volume":"2","author":"Romine","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1021\/acs.joc.3c01861","article-title":"Turn-Mimic Hydantoin-Based Loops Constructed by a Sequential Multicomponent Reaction","volume":"88","author":"Caramiello","year":"2023","journal-title":"J. Org. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1021\/acs.joc.2c01903","article-title":"Synthesis and Conformational Analysis of Hydantoin-Based Universal Peptidomimetics","volume":"88","author":"Caramiello","year":"2023","journal-title":"J. Org. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00044-025-03427-z","article-title":"Synthesis and in vitro study of a novel catechol with a hydantoin core","volume":"34","author":"Bai","year":"2025","journal-title":"Med. Chem. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Alanazi, F.S., Alkahtani, H.M., Abdel-Aziz, A.A.-M., El-Azab, A.S., Asiri, H.H., Bakheit, A.H., and Al-Omary, F.A. (2025). Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff\u2019s Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition Activities. Pharmaceuticals, 18.","DOI":"10.3390\/ph18040496"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1080\/17568919.2024.2366694","article-title":"In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety","volume":"16","author":"Binjawhar","year":"2024","journal-title":"Future Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/1568026623666230106121527","article-title":"Study on Molecular Anti-tumor Mechanism of 2-Thiohydantoin Derivative based on Molecular Docking and Bioinformatic Analyses","volume":"23","author":"Mutlaq","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115490","DOI":"10.1016\/j.ejmech.2023.115490","article-title":"Discovery of thiohydantoin based antagonists of androgen receptor with efficient degradation for the treatment of prostate cancer","volume":"257","author":"Chang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s11030-023-10653-3","article-title":"Synthesis of bis-thiohydantoin derivatives as antiproliferative agents targeting EGFR inhibitory pathway","volume":"28","author":"Hassan","year":"2024","journal-title":"Mol. Divers."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jurin, M., \u010ciko\u0161, A., Stepani\u0107, V., G\u00f3recki, M., Pescitelli, G., Kontrec, D., Jakas, A., Dra\u017ei\u0107, T., and Roje, M. (2024). Synthesis, Absolute Configuration, Biological Profile and Antiproliferative Activity of New 3,5-Disubstituted Hydantoins. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101259"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112196","DOI":"10.1016\/j.ejmech.2020.112196","article-title":"Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists","volume":"192","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/fmc-2019-0276","article-title":"Design, synthesis and anticancer evaluation of \u03b2-carboline-1-one hydantoins","volume":"12","author":"Yao","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"112435","DOI":"10.1016\/j.ejmech.2020.112435","article-title":"Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma","volume":"200","author":"Ali","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acsmedchemlett.1c00032","article-title":"Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115953","DOI":"10.1016\/j.bmc.2020.115953","article-title":"Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer","volume":"31","author":"Wang","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2174\/1871520621666210811102441","article-title":"Patterns of Cell Death Induced by Thiohydantoins in Human MCF-7 Breast Cancer Cells","volume":"22","author":"Fagundes","year":"2022","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hassanin, M.A., Mustafa, M., Abourehab, M.A.S., Hassan, H.A., Aly, O.M., and Beshr, E.A.M. (2022). Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFR L858R\/T790M Mutations. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070857"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"104527","DOI":"10.1016\/j.bioorg.2020.104527","article-title":"Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy","volume":"107","author":"Upadhyay","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"117945","DOI":"10.1016\/j.ejmech.2025.117945","article-title":"Discovery and structure-activity relationship study of novel hydantoin-based inhibitors targeting mutant isocitrate dehydrogenase 1 (mIDH1)","volume":"297","author":"Luo","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_38","first-page":"1","article-title":"3\u2032-Methyl-4-thio-1H-tetrahydropyranspiro-5\u2032-hydantoin platinum complex as a novel deoxyribonuclease I inhibitor","volume":"71","author":"Atanasova","year":"2024","journal-title":"Pharmacia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105643","DOI":"10.1016\/j.bioorg.2022.105643","article-title":"Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors","volume":"121","author":"Liang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/acs.jmedchem.3c02036","article-title":"BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor","volume":"67","author":"Meibom","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1021\/acs.jmedchem.3c02396","article-title":"Discovery and Optimization of Selective Brain-Penetrant EBP Inhibitors that Enhance Oligodendrocyte Formation","volume":"67","author":"Dorel","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Schneider, N.O., Gilreath, K., Burkett, D.J., Maurice, M.S., and Donaldson, W.A. (2024). Synthesis and Evaluation of 5-(Heteroarylmethylene) hydantoins as Glycogen Synthase Kinase-3\u03b2 Inhibitors. Pharmaceuticals, 17.","DOI":"10.3390\/ph17050570"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115147","DOI":"10.1016\/j.ejmech.2023.115147","article-title":"Investigation of tetrasubstituted heterocycles reveals hydantoins as a promising scaffold for development of novel antimicrobials with membranolytic properties","volume":"249","author":"Langer","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1039\/D4MD00374H","article-title":"Hydantoin derivative dimers as broad-spectrum antimicrobial agents against ESKAPE pathogens with enhanced killing rate and stability","volume":"15","author":"Chen","year":"2024","journal-title":"RSC Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e1900352","DOI":"10.1002\/ardp.201900352","article-title":"Synthesis of imidazolidine-2,4-dione and 2-thioxoimidazolidin-4-one derivatives as inhibitors of virulence factors production in Pseudomonas aeruginosa","volume":"353","author":"Mohamed","year":"2020","journal-title":"Arch. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.jmedchem.0c00107","article-title":"Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-\u03b2-d- Ribose Oxidase (DprE1) Inhibitors","volume":"63","author":"Balabon","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"137565","DOI":"10.1016\/j.molstruc.2024.137565","article-title":"New bis-hydantoin\/thiohydantoin derivatives: Regioselective synthesis, antibacterial activity, molecular docking, and computational insights","volume":"1303","author":"Khodair","year":"2024","journal-title":"J. Mol. Struct."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100319","DOI":"10.1016\/j.chphi.2023.100319","article-title":"Synthesis, antimicrobial activity and molecular docking studies of novel hydantoin derivatives as potential phospholipase A2 inhibitors","volume":"7","author":"Theodore","year":"2023","journal-title":"Chem. Phys. Impact"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1039\/C9OB01339C","article-title":"Hydantoin analogs inhibit the fully assembled ClpXP protease without affecting the individual peptidase and chaperone domains","volume":"17","author":"Fetzer","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2400733","DOI":"10.1002\/ardp.202400733","article-title":"Novel derivatives of thiohydantoin-containing tetrahydro-\u03b2-carboline possess activity against influenza virus at late stages of viral cycle without affecting viral neuraminidase","volume":"358","author":"Khachatryan","year":"2025","journal-title":"Arch. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pardali, V., Giannakopoulou, E., Mpekoulis, G., Tsopela, V., Panos, G., Taylor, M.C., Kelly, J.M., Vassilaki, N., and Zoidis, G. (2023). Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity. Pharmaceuticals, 16.","DOI":"10.3390\/ph16071046"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e202400612","DOI":"10.1002\/cmdc.202400612","article-title":"Synthesis, Anticonvulsant, Antinociceptive Activity and Preliminary Safety Evaluations of Novel Hybrid Imidazolidine-2,4-Dione Derivatives with Morpholine Moiety","volume":"20","author":"Czopek","year":"2025","journal-title":"ChemMedChem"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1021\/acschemneuro.4c00152","article-title":"The Importance of Stereochemistry in 5-HT7R Modulation-A Case Study of Hydantoin Derivatives","volume":"15","author":"Podlewska","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e202400102","DOI":"10.1002\/cmdc.202400102","article-title":"Investigation into Novel Mukanadin B, Mukanadin D and Mukanadin F Derivatives as Antagonists of 5-HT1A Signalling","volume":"19","author":"Rees","year":"2024","journal-title":"ChemMedChem"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e202400533","DOI":"10.1002\/cmdc.202400533","article-title":"Investigation of Novel Isatinylhydantoin Derivatives as Potential Anti-Kinetoplastid Agents","volume":"20","author":"Sechoaro","year":"2025","journal-title":"ChemMedChem"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e70125","DOI":"10.1002\/ddr.70125","article-title":"In Vitro Leishmanicidal Efficacy of Synthesized Arylidene Analogues of Glitazone","volume":"86","author":"Aucamp","year":"2025","journal-title":"Drug Dev. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"129701","DOI":"10.1016\/j.bmcl.2024.129701","article-title":"Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents","volume":"103","author":"Chin","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/acsinfecdis.4c00677","article-title":"Single-Dose Drug Development Candidate for Schistosomiasis","volume":"10","author":"Leas","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"111646","DOI":"10.1016\/j.molbiopara.2024.111646","article-title":"Therapeutic potential of hydantoin and thiohydantoin compounds against Schistosoma mansoni: An integrated in vitro, DNA, ultrastructural, and ADMET in silico approach","volume":"260","author":"Leal","year":"2024","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00044-021-02781-y","article-title":"Benzoxazolyl linked benzylidene based rhodanine and analogs as novel antidiabetic agents: Synthesis, molecular docking, and in vitro studies","volume":"30","author":"Singh","year":"2021","journal-title":"Med. Chem. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Khirallah, S.M., Ramadan, H.M.M., Aladl, H.A.A., Ayaz, N.O., Kurdi, L.A.F., Jaremko, M., Alshawwa, S.Z., and Saied, E.M. (2025). Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazolidin-4-One Analogues: Insights into \u03b1-Glucosidase, \u03b1-Amylase, and Antioxidant Activities. Pharmaceuticals, 15.","DOI":"10.3390\/ph15121576"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"28100","DOI":"10.1038\/s41598-025-13538-7","article-title":"Synthesis and evaluation of novel thiohydantoin derivatives for antidiabetic activity using in silico in vitro and in vivo methods","volume":"15","author":"Bukhari","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141802","DOI":"10.1016\/j.molstruc.2025.141802","article-title":"Antihyperglycemic hydantoin derivative: Design, molecular docking, synthesis, crystal structure, computational studies, pharmacological and toxicological activities","volume":"1333","author":"Guerrab","year":"2025","journal-title":"J. Mol. Struct."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acs.jmedchem.0c02008","article-title":"Discovery of GLPG1972\/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis","volume":"64","author":"Brebion","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cbdd.14017","article-title":"Structure-based discovery of (S)-2-amino-6-(4-fluorobenzyl)-5,6,11,11a-tetrahydro-1H-imidazo [1\u2032,5\u2032:1,6]pyrido [3,4-b]indole-1,3(2H)-dione as low nanomolar, orally bioavailable autotaxin inhibitor","volume":"99","author":"Roy","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"108092","DOI":"10.1016\/j.intimp.2021.108092","article-title":"The indole-hydantoin derivative exhibits anti-inflammatory activity by preventing the transactivation of NF-\u03baB through the inhibition of NF-\u03baB p65 phosphorylation at Ser276","volume":"100","author":"Lin","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2335927","DOI":"10.1080\/14756366.2024.2335927","article-title":"Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide\u2013hydantoin hybrids","volume":"39","author":"Abdoli","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1021\/acs.jafc.2c09144","article-title":"Design, Synthesis, and Antifungal\/Antioomycete Activity of Thiohydantoin Analogues Containing Spirocyclic Butenolide","volume":"71","author":"Li","year":"2023","journal-title":"J. Agric. Food Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/5\/779\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:18:55Z","timestamp":1772255935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/5\/779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["molecules31050779"],"URL":"https:\/\/doi.org\/10.3390\/molecules31050779","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}